Natura &Co will volutarily delist from the New York Stock Exchange (NYSE). The Brazilian cosmetics maker will maintain its primary listing of common shares on the B3 stock exchange in São Paulo. According to the company, the vast majority of Natura &Co trading activity is concentrated on the B3 stock exchange. The decreasing trading volume of Natura &Co's American Depository Shares on the NYSE no longer makes maintaining the listing a compelling option. Natura is ranked No. 9 in Happi's most recent version of The International Top 30.
"The planned delisting of Natura &Co from the New York Stock Exchange is consistent with our long-term strategy for the business," explained Natura CEO Fabio Barbosa"This move underscores our continued focus on simplifying our operations to reduce complexity. We thank Natura &Co investors who held ADRs and look forward to welcoming many of them as shareholders on the B3 market. Upholding our dedication to transparency, we will maintain our high disclosure standards through our listing in Brazil."
Natura &Co expects the NYSE to suspend trading in the ADSs on or about Feb. 9, 2024.
Related Content:
Natura Patents Anti-Wrinkle Treatment